Citigroup Inc Concert Pharmaceuticals, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$4.34 - $5.84 $318,438 - $428,498	73,373 Added 60.78%	194,090 $1.13 Million
Q3 2022 Nov 10, 2022	BUY	$4.27 - $7.2 $515,461 - $869,162	120,717 New	120,717 $809,000
Q4 2021 Feb 10, 2022	SELL	$2.69 - $4.22 $4,489 - $7,043	-1,669 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.17 - $4.15 $5,290 - $6,926	1,669 New	1,669 $5,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.